ArticleHeliyon2020
In-vitro anticancer activity against Caco-2 cell line of colloidal nano silver synthesized using aqueous extract of
Article in Heliyon, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Clove-mediated green synthesis of silver nanoparticles andFrontiers in microbiology · 2026Article
- Biosynthesis of silver nanoparticles from plant extracts: a comprehensive review focused on anticancer therapy.Frontiers in pharmacology · 2025Review
- Silver Nanoparticles Seed Priming for Sustainable Enhancement of Durum Wheat Growth, Yield, and Nutrient Enrichment.IET nanobiotechnology · 2025Article
- Squalene in Nanoparticles Improves Antiproliferative Effect on Human Colon Carcinoma Cells Through Apoptosis by Disturbances in Redox Balance.International journal of molecular sciences · 2024Article
- Anticancer Properties of Saccharomyces boulardii Metabolite Against Colon Cancer Cells.Probiotics and antimicrobial proteins · 2024Article
- Chinese bayberry (Frontiers in pharmacology · 2024Article
- Green Synthesis of Silver Nanoparticles Derived fromMolecules (Basel, Switzerland) · 2023Article
- Nanocarriers for the Delivery of Neuroprotective Agents in the Treatment of Ocular Neurodegenerative Diseases.Pharmaceutics · 2023Review
- Development of an efficient method for separation and purification of cordycepin from liquid fermentation ofHeliyon · 2023Article
- Investigation of Cytotoxicity of Biosynthesized Colloidal Nanosilver against LocalMaterials (Basel, Switzerland) · 2022Article
- Influence of Polyvinylpyrrolidone Concentration on Properties and Anti-Bacterial Activity of Green Synthesized Silver Nanoparticles.Micromachines · 2022Article
- Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence.Pharmaceutics · 2022Review
- Effect of Coated Silver Nanoparticles on Cancerous vs. Healthy Cells.Journal of toxicology · 2022Article
- Investigation of Antimicrobial and Cytotoxic Properties and Specification of Silver Nanoparticles (AgNPs) Derived FromFrontiers in bioengineering and biotechnology · 2022Article
- Bioinformatic Analysis of the Effect of Silver Nanoparticles on Colorectal Cancer Cell Line.BioMed research international · 2022Article
- Article
- Toward a Better Understanding of Metal Nanoparticles, a Novel Strategy fromPlants (Basel, Switzerland) · 2021Review
- Biosynthesis of Silver Nanoparticles by Marine ActinobacteriumFrontiers in microbiology · 2021Article
- Bactericidal and In-Vitro Cytotoxic Efficacy of Silver Nanoparticles (Ag-NPs) Fabricated by Endophytic Actinomycetes and Their Use as Coating for the Textile Fabrics.Nanomaterials (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the current study, we investigated the anticancer potential against human colon cells (Caco-2) of colloidal nanosilver (CN-Ag) produced in Syria using bioactive compounds in the aqueous extract of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.